Artisan Partners’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$29.6M	Buy	+1,331,813	New	+$31.8M	0.05%	260
2022 Q3	–	Sell	-316,293	Closed	-$4.46M	–	314
2022 Q2	$4.46M	Sell	316,293 -910,678	-74%	-$17M	0.01%	303
2022 Q1	$29.7M	Sell	1,226,971 -167,868	-12%	-$4.06M	0.04%	266
2021 Q4	$32.6M	Sell	1,394,839 -38,119	-3%	-$767K	0.04%	277
2021 Q3	$23.8M	Sell	1,432,958 -11,224	-0.8%	-$216K	0.03%	286
2021 Q2	$35.2M	Sell	1,444,182 -113,618	-7%	-$2.56M	0.04%	269
2021 Q1	$40.2M	Buy	1,557,800 +199,130	+15%	+$8.77M	0.05%	268
2020 Q4	$72.6M	Buy	1,358,670 +361,728	+36%	+$18M	0.09%	208
2020 Q3	$41.1M	Sell	996,942 -331,767	-25%	-$14.3M	0.06%	238
2020 Q2	$64.4M	Buy	1,328,709 +64,541	+5%	+$3.1M	0.1%	178
2020 Q1	$53.4M	Sell	1,264,168 -39,372	-3%	-$1.62M	0.12%	172
2019 Q4	$55.8M	Sell	1,303,540 -243,665	-16%	-$10.6M	0.1%	174
2019 Q3	$55.7M	Sell	1,547,205 -7,453	-0.5%	-$226K	0.11%	170
2019 Q2	$41.6M	Buy	1,554,658 +422,829	+37%	+$10.8M	0.08%	191
2019 Q1	$30.4M	Buy	1,131,829 +879,311	+348%	+$20.5M	0.06%	207
2018 Q4	$4.08M	Buy	+252,518	New	+$4.9M	0.01%	252